| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |